These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 30279742)
1. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts. El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742 [No Abstract] [Full Text] [Related]
2. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging. Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640 [TBL] [Abstract][Full Text] [Related]
3. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments. Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810 [TBL] [Abstract][Full Text] [Related]
4. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096 [No Abstract] [Full Text] [Related]
5. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery. Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129 [TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. Schneider DW; Heitner T; Alicke B; Light DR; McLean K; Satozawa N; Parry G; Yoo J; Lewis JS; Parry R J Nucl Med; 2009 Mar; 50(3):435-43. PubMed ID: 19223400 [TBL] [Abstract][Full Text] [Related]
7. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for Zettlitz KA; Waldmann CM; Tsai WK; Tavaré R; Collins J; Murphy JM; Wu AM J Nucl Med; 2019 Oct; 60(10):1467-1473. PubMed ID: 30877181 [TBL] [Abstract][Full Text] [Related]
11. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation. Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880 [TBL] [Abstract][Full Text] [Related]
13. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system. Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951 [TBL] [Abstract][Full Text] [Related]
14. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029 [TBL] [Abstract][Full Text] [Related]
15. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody. Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882 [TBL] [Abstract][Full Text] [Related]
17. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody. Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820 [TBL] [Abstract][Full Text] [Related]
18. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer. Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001 [TBL] [Abstract][Full Text] [Related]